Position in SVTR
Snapshot 2026-10-28- Startup SignalsTop 50%new
- Life SciencesTop 50%
- Medtech DeviceTop 50%
- Synthetic Data#6of 14
About
Adsilico is a computational medicine company spun out of the University of Leeds (with the University of Manchester) that uses generative AI on anonymized clinical scans to build virtual patient populations and physics-based simulations, letting medical device makers run in-silico trials before human studies.
Full tier & rationale — an SVTR Intelligence benefit
Capital graph
Investor· 3
Founders / team· 4
Funding history
- 2026-10-26Series A$14M
Investors · PXN Ventures, Northern Gritstone, ParkwalkSource · techfundingnews.com ↗
Comparable companies· by market
This company
BusinessLatest roundTotal raisedDate- Adsilico
Generative AI that builds virtual patient cohorts for in-silico trials run by medical device makers
Series A · $18M · 2026-10
$18M
United States
BusinessLatest roundTotal raisedDate- Inner Logic
AI simulation and data infrastructure for surgical/interventional devices: testing on thousands of virtual patients, enabling surgical autonomy
Seed · $12M · 2026-07
$12M - Nervonik
Implantable peripheral nerve stimulation devices using electrical signals and real-time sensing for personalized chronic pain treatment
Series B · $53M · 2026-05
$53M - Proprio
AI-driven surgical platform startup building a system that makes surgeons more precise and multiplies surgical accuracy and efficiency
Series B · $43M · 2023-08
$43M
China
BusinessLatest roundTotal raisedDate- BCI-Sonics
Non-invasive AI ultrasound brain-computer interface (transcranial focused ultrasound neuromodulation + multimodal brain reading and AI neural decoding)
Series A · $42M · 2026-09
$42M - Kossel Medtech
R&D and manufacturing of pan-vascular interventional devices (peripheral intervention, coronary, electrophysiology, core raw materials), plus OEM/CDMO services for implantable devices
Series C · 2026-09
— - Jiangsu Apon Medical Technology Co., Ltd.
R&D, manufacturing and sales of pain management devices (electronic analgesia pumps, wireless analgesia management systems) and nasal and upper airway care devices; expanding into brain-computer interface medical applications (perioperative brain state monitoring, insomnia anesthesia therapy systems, multimodal ADHD behavioral therapy management systems).
—
Europe
BusinessLatest roundTotal raisedDate- Mantra Systems
EU MDR/IVDR and UKCA compliance consulting, clinical evaluation report (CER) writing, post-market clinical follow-up (PMCF), real-world evidence assessment, SaMD/AIaMD regulatory assessment, technical documentation and quality system advisory, and European market entry for US companies, for medical device manufacturers
— - Hypervision Surgical
Surgical intelligence venture incubated at King's College London; AI-driven hyperspectral imaging assesses tissue status in real time during surgery
Series A · $23M · 2026-05
$23M - MintNeuro
Imperial College London spinout developing composable chip modules for neural signal acquisition, electrical stimulation, on-chip processing and wireless transmission, for BCI and active implant makers
Undisclosed · 2026-10
—
Other / unspecified
BusinessLatest roundTotal raisedDate- Sound Blade Medical
Handheld device that uses focused ultrasound to break down diseased tissue non-invasively
Series A · $17M · 2025-02
$17M - UltraSight
AI-guided cardiac ultrasound workflow platform (Echosystem) enabling non-specialist clinicians to perform diagnostic-grade echocardiograms at the bedside
Series B · $42M · 2026-09
$42M - CustoMED
AI and 3D printing to produce patient-specific orthopedic surgical tools and implants
Seed · $6M · 2025-11
$6M
Confirmed rounds only. Matched on subsector, sector, stage and funding scale — each verifiable on the company profiles.
Investors that may fit
General Catalyst
40 Life Sciences deals in the last 24 months · 26 at a nearby stage · 1 in Western Europe
Request intro →Y Combinator
39 Life Sciences deals in the last 24 months · 34 at a nearby stage · 3 in Western Europe
Request intro →Thrive Capital
18 Life Sciences deals in the last 24 months · 6 at a nearby stage · 3 in Western Europe
Request intro →GV
14 Life Sciences deals in the last 24 months · 6 at a nearby stage · 3 in Western Europe
Request intro →Alumni Ventures
12 Life Sciences deals in the last 24 months · 10 at a nearby stage · 1 in Western Europe
Request intro →Accel
12 Life Sciences deals in the last 24 months · 9 at a nearby stage · 3 in Western Europe
Request intro →Ranked by each firm’s deals in this sector over the last 24 months, weighted by nearby stage and shared geography. Indicative only — no rating judgment.